3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
53
Thoracic
16
Genitourinary
10
Head & Neck
8
Other
7
Lymphoid
6
Breast
6
Other hematologic neoplasm
4
Gynecologic
4
Plasma cell
2
Myeloid
2
Classical hematology
2
Sarcoma
1
Dermatologic
1
Conditions
Leukemia, Myeloid, Acute
191
Anemia, Refractory, with Excess of Blasts
179
Myelodysplastic Syndromes
175
Leukemia
168
Precursor Cell Lymphoblastic Leukemia-Lymphoma
132
Neoplasms
121
Multiple Myeloma
116
Venous Thromboembolism
111
Anemia
108
Leukemia, Myelomonocytic, Chronic
103
Leukemia, Lymphocytic, Chronic, B-Cell
100
Myeloproliferative Disorders
99
Lymphoma, Non-Hodgkin
97
Lymphoma
96
Hodgkin Disease
85
Thrombocytopenia
84
Anemia, Aplastic
79
Primary Myelofibrosis
67
Lymphoma, Follicular
67
Hematologic Neoplasms
63
Leukemia, Myeloid, Chronic-Phase
61
Lymphoma, Mantle-Cell
59
Febrile Neutropenia
59
Congenital Abnormalities
59
Neoplasms, Plasma Cell
57
Leukemia, Myeloid, Accelerated Phase
57
Anemia, Refractory
57
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
56
Blast Crisis
56
Burkitt Lymphoma
53
Interventions
nicotinamide-beta-riboside
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Sarcopenia
×
Classical hematology
×
Clear all
NCT05194397
2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2
Recruiting
80 enrolled
NCT05154474
2022-05-03
SPACE2
Weprom
Unknown
150 enrolled